For the Inventor, By the Inventor

Enter assignee name

Miami, FL, United States of America

Kos Pharmaceuticals, Incorporated

USPTO Granted Patents = 15

% Expired Patents = 33.3

Trademarks = 2

Forward Citations = 247

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Jose Gutierrez-Rocca (4 out of 5 patents)

Eugenio A Cefali (4 out of 4 patents)

Theoharis C Theoharides (3 out of 20 patents)

4. David J Bova (3 out of 6 patents)

5. Josephine Dunne (3 out of 3 patents)

6. Saul A Rios (2 out of 2 patents)

7. Akwete Lex Adjei (1 out of 34 patents)

8. Stephen G Hauser (1 out of 46 patents)

9. Vassilis I Zannis (1 out of 2 patents)

10. Kypreos E Kyriakos (1 out of 1 patent)

11. Yazping Zhu (1 out of 1 patent)

12. Federick Sexton (1 out of 1 patent)

13. Hossein Omidian (1 out of 2 patents)

14. Perry Arthur Genova (1 out of 61 patents)

15 patents: Sort by Forward Citations

1. 7309606 - Methods and compositions for treating hypercholesterolemia (2007-12-18),

2. 7056957 - Formation of strong superporous hydrogels (2006-06-06),

3. 7056494 - Method of treating a systemic disease (2006-06-06),

4. 7011848 - Hydrophobic component free sustained release nicotinic acid compositions for treating hyperlipidemia and related methods therefor (2006-03-14),

5. 6818229 - Intermediate release nicotinic acid compositions for treating hyperlipidemia (2004-11-16),

6. 6746691 - Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics (2004-06-08),

7. 6676967 - Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia (2004-01-13),

8. 6596308 - Controlled release pharmaceutical composition (2003-07-22),

9. 6524615 - Controlled release pharmaceutical composition (2003-02-25),

10. 6491950 - Controlled release pharmaceutical composition (2002-12-10),

11. 6406715 - Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique urinary metabolite profiles (2002-06-18),

12. 6155251 - Breath coordinated inhaler (2000-12-05),

13. 6020305 - Treatment of stress-induced skin disease by corticotropin releasing (2000-02-01),

14. 5855884 - Treatment of stress-induced migraine headache with a corticotropin (1999-01-05),

15. 5250529 - Method alleviating migraine headache with mast cell degranulation (1993-10-05),

Kos Pharmaceuticals, Incorporated is a biopharmaceutical company based in Miami, Florida, specializing in the development and commercialization of innovative therapies for various medical conditions. The company focuses on areas such as cardiovascular health and metabolic disorders, leveraging advanced research and technology to create effective treatment options. With a commitment to improving patient outcomes, Kos Pharmaceuticals aims to address unmet medical needs through its specialized product offerings and ongoing research initiatives.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

15 Patents

#55 in Miami, FL

#576 in Florida

#21,034 in US

#39,881 in the World

Miami, FL, United States of America

Kos Pharmaceuticals, Incorporated

Forward Citations = 247

14 inventors:

Jose Gutierrez-Rocca (4 out of 5 patents)

Eugenio A Cefali (4 out of 4 patents)

Theoharis C Theoharides (3 out of 20 patents)

4. David J Bova (3 out of 6 patents)

5. Josephine Dunne (3 out of 3 patents)

Please report any incorrect information to [email protected]

Loading…